Recombinant Mouse Anti-NUDCD1 Recombinant Antibody (AR55-1-4) (CBMAB-XB0892-YC)

Wen, W., Li, Y., Cao, X., Li, Y., Liu, Z., Tang, Z., ... & He, R. (2024). Expression and clinical significance of NUDCD1, PI3K/AKT/mTOR signaling pathway-related molecules and immune infiltration in breast cancer. Clinical Breast Cancer.

Han, B., He, J., Chen, Q., Yuan, M., Zeng, X., Li, Y., ... & Ma, D. (2023). Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation. Aging (Albany NY), 15(12), 5611.

Zhu, M., Liu, N., Lin, J., Wang, J., Lai, H., & Liu, Y. (2023). HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple‑negative breast cancer. Oncology Letters, 25(1), 1-14.

Han, B., He, J., Li, Y., Chen, Q., Yuan, M., Zeng, X., ... & Ma, D. (2022). Identifying the Role of NUDCD1 in Human Tumors from Clinical and Molecular Mechanisms.

Feng, W. M., Gong, H., Wang, Y. C., Wang, Y., Xue, T., Zhang, T., & Cui, G. (2022). NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways. BMC cancer, 22(1), 981.

Han, B., Xu, K., Feng, D., Bai, Y., Liu, Y., Zhang, Y., & Zhou, L. (2022). miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification. Journal of Cancer Research and Clinical Oncology, 148(8), 1903-1918.

Shi, C., Weng, M., Zhu, H., Guo, Y., Xu, D., Jin, H., ... & Cao, Z. (2021). NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process. Aging (Albany NY), 13(14), 18298.

He, B., Xia, S., & Zhang, Z. (2020). NudCD1 promotes the proliferation and metastasis of non-small cell lung cancer cells through the activation of IGF1R-ERK1/2. Pathobiology, 87(4), 244-253.

Liu, Y. P., Wei, W., He, Y., You, C. J., & Lei, C. J. (2020). Analysis of NudCD1 and NF-κΒ in the early detection and course evaluation of renal cancer. Eur Rev Med Pharmacol Sci, 24(23), 12109-12115.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Isotype control